CB Insights January 3, 2024
Isabelle Selles

Here’s the data on a potential telehealth merger.

This analysis is part of our series on 2024 M&A predictions. See all 10 matchups here.

Hims & Hers is a rare SPAC that has not cratered in the public markets.

Ro, a telehealth platform which remains private, was last valued at $7B in February 2022. However, this valuation is likely somewhat inflated given it came towards the end of the fundraising boom.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Mergers & Acquisitions / JV, Technology, Telehealth, Trends
Amwell’s Roy Schoenberg talks about telehealth and broader views of virtual care
The telehealth background of Trump's FDA pick: 6 notes
Teladoc expands virtual sitter capabilities
AHA, others urge Congress to act on alternative payment models, avoid physician payment cut
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?

Share This Article